The homolog of IL-23R-CHR genes between human and mouse is 84%, this human recombinant protein sequence could serve as a molecular probe to investigate the therapeutic effect of IL-23 antagonist in autoimmune diseases characterized by high expression of IL-23 and abnormal proliferation of Th17 cells. This evidence concerns the gene IL23R and autoimmune disease.